Most Recent

Contributors

By | September 1, 2013

Meet some of the people featured in the September 2013 issue of The Scientist.

0 Comments

image: Going Viral

Going Viral

By | September 1, 2013

Bacteriophages shuttle genes between diverse ecosystems.

1 Comment

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

image: You Are <em>When</em> You Eat

You Are When You Eat

By | September 1, 2013

Circadian time zones and metabolism

0 Comments

image: Going Viral

Going Viral

By | September 1, 2013

From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.

6 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: Why One Cream Cake Leads to Another

Why One Cream Cake Leads to Another

By | August 15, 2013

Continuously eating fatty foods perturbs communication between the gut and brain, which in turn perpetuates a bad diet.

8 Comments

image: Cancer-Causing Herbal Remedies

Cancer-Causing Herbal Remedies

By | August 7, 2013

A potent carcinogen lurks within certain traditional Chinese medicines.

15 Comments

image: STW: In the Field

STW: In the Field

By | August 1, 2013

Scientist to Watch Josh Snodgrass has traveled the world, from Siberia to South America, to study how the physiology of indigenous peoples shifts with changing lifestyles.

0 Comments

image: Josh Snodgrass: An Adaptive Mind

Josh Snodgrass: An Adaptive Mind

By | August 1, 2013

Associate Professor, Department of Anthropology, University of Oregon. Age: 41

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech